New Edge Advisors, LLC Lantern Pharma Inc. Put Options Transaction History
New Edge Advisors, LLC
- $18.3 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding LTRN
# of Institutions
35Shares Held
2.22MCall Options Held
16.4KPut Options Held
0-
Bios Capital Management, LP Fort Worth, TX1.08MShares$4.79 Million4.68% of portfolio
-
Vanguard Group Inc Valley Forge, PA364KShares$1.62 Million0.0% of portfolio
-
Cm Management, LLC200KShares$890,0000.65% of portfolio
-
Geode Capital Management, LLC Boston, MA91.9KShares$408,9140.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny90.6KShares$403,1700.0% of portfolio
About Lantern Pharma Inc.
- Ticker LTRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,830,900
- Market Cap $48.2M
- Description
- Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...